Nalp3 inflammasome modulator (Opsona)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNalp3 inflammasome modulator (Opsona)
Drug Alias NameIL-1beta inhibitor (Opsona)interleukin-1beta inhibitor (Opsona)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 modulatorsInterleukin-1 beta inhibitors
TargetsInterleukin-1 betaNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpsona Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpsona Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A